San Diego, CA (PRWEB) June 27, 2013
http://www.resource4thepeople.com/defectivemedicaldevices/Dialysis-Lawsuit.html

Resource4thePeople reports nowadays on its most current update to shoppers who are following the litigation involving allegations that Fresenius NaturaLyte and GranuFlo kidney dialysis products brought on life-threatening troubles for individuals.

The most current news is that as a federal judge moves forward on consolidated federal lawsuits* involving these allegations a search of U.S. Food and Drug Administration records shows that Fresenius was cited** by federal regulators more than deficiencies uncovered at 1 of the companys facilities.

In a warning letter dated March 13, 2013, FDA officials informed Fresenius Health-related Care officials that dialyzers manufactured at the companys Ogden, Utah plant are not in conformity with existing federal good manufacturing requirements.

The FDAs warning letter additional calls into query the good quality of goods that Fresenius is producing for kidney individuals and comes at a time when the federal court method has consolidated situations from across the nation containing allegations that GranuFlo and NaturaLyte allegedly have life-threatening side effects, stated Resource4thePeople.

We will continue to supply updates for shoppers who may possibly have been impacted by these dialysis goods and will report on the progress of the federal consolidated litigation. We also will continue to offer buyers free consultations about legal rights to which they may be entitled to seek compensation.

At least 161 federal NaturaLyte and GranuFlo lawsuits alleging severe heart difficulties and deaths from the use of these merchandise have been consolidated ahead of U.S. District Court Judge Douglas P. Woodlock, according to the court docket.*

The court filings also summarize the particular allegations involved that plaintiffs who used NaturaLyte and GranuFlo claim they must be compensated for:

These actions share factual troubles arising from allegations that Plaintiffs suffered injury or death brought on by the use of GranuFlo and/or NaturaLyte products in the course of hemodialysis, which allegedly might cause metabolic alkalosis in sufferers resulting in low blood stress, hypokalemia, hypoxemia, hypercapnia, cardiac arrhythmia, or cardiopulmonary arrest.

All the actions involve factual concerns relating to whether or not GranuFlo and NaturaLyte were defectively developed or manufactured, no matter whether Fresenius, the manufacturer of these dialysate goods, knew or ought to have known of the alleged propensity of these merchandise to result in injury and whether or not it supplied adequate directions and warnings with these goods.

Resource4thePeople, in response to inquiries from consumers, is informing them that even although this multidistrict litigation has been produced new inquiries will nevertheless be accepted and further circumstances will continue to be filed.

Amongst numerous new situations that have been not too long ago filed are those by:

